All Indian vaccines being developed for storage at 2-8 degree Celsius: DBT secretary

Swarup said Dr Reddy's Laboratories has partnered with Russia's Gamaleya Institute and a vaccine is being developed for India targeting storage at 2-8 degrees Celsius. The country's drugs regulator Sunday granted emergency use approval to Oxford-AstraZeneca's Covishield and also to the indigenously developed Covaxin even though not enough data on the latter's efficacy and safety was available, which has triggered a debate.